Old Web
English
Sign In
Acemap
>
authorDetail
>
A Vilches-Arenas
A Vilches-Arenas
Medicine
Physical therapy
Infliximab
Adenoma
Urology
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P391 Are cut-off ranges of Infliximab serum levels in Crohn’s disease always the same in clinical practice?
2019
Journal of Crohns & Colitis
T Valdes Delgado
M Guerra Veloz
M Belvis Jimenez
B Maldonado Pérez
L. Castro Laria
A. Benítez Roldán
R. Perea Amarillo
V. Merino Bohórquez
M.A. Calleja-Hernández
T. Ortiz
Á Caunedo Álvarez
A Vilches-Arenas
A Saez Diaz
Federico Argüelles-Arias
Show All
Source
Cite
Save
Citations (0)
P335 Long-term follow-up of switching from original infliximab to infliximab biosimilar: real-world data
2019
Journal of Crohns & Colitis
M Guerra Veloz
M Belvis Jimenez
T Valdes Delgado
L. Castro Laria
B Maldonado Pérez
A. Benítez Roldán
R. Perea Amarillo
V. Merino Bohórquez
M.A. Calleja-Hernández
Á Caunedo Álvarez
A Vilches-Arenas
Federico Argüelles-Arias
Show All
Source
Cite
Save
Citations (0)
Adenoma metanefrico: presentación de 2 casos y revisión de la literatura
2017
Archivos españoles de urología
E Rodríguez-Zarco
Ana Vallejo-Benítez
Fj Farfán-López
A Vilches-Arenas
Sofia Pereira Gallardo
Fj Vázquez-Ramírez
Show All
Source
Cite
Save
Citations (0)
1